• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Finance
  • Payers
  • Regulatory
  • Special Reports
  • Podcasts
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Finance
  • Payers
  • Regulatory
  • Special Reports
  • Podcasts
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Jason Gorevic

Health Tech

Teladoc CEO bullish on growth despite rough Q1, falling stock

Teladoc CEO Jason Gorevic is bullish that Teladoc can win in the market in the long run despite current market volatility and growing competition.
Heather Landi Jun 30, 2022 6:12am

Teladoc stock turbulent on Q4 earnings with modest 2022 guidance

Feb 23, 2022 1:00pm

Teladoc projects $2.03B in 2021 revenue

Jan 10, 2022 10:50am

Teladoc plans to take on risk with virtual primary care

Nov 1, 2021 8:15am

Teladoc stock slides after Q2 losses but revenue jumps 109%

Jul 28, 2021 9:25am

Teladoc CEO bullish on fending off rivals in telehealth space

May 12, 2021 10:08am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy